Osaic Holdings
NAGE

Osaic Holdings’s Niagen Bioscience NAGE Stock Holding History

Osaic Holdings’s Portfolio NAGE Stock Details NAGE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$82.7K Buy
25,922
+22,825
+737% +$92.6K ﹤0.01% 5107
2026
Q1 		$13.7K Sell
3,097
-19,264
-86% -$104K ﹤0.01% 6111
2025
Q4 		$142K Buy
22,361
+4,784
+27% +$33.3K ﹤0.01% 4410
2025
Q3 		$173K Buy
17,577
+10,768
+158% +$109K ﹤0.01% 4350
2025
Q2 		$98.1K Buy
6,809
+5,066
+291% +$50K ﹤0.01% 4518
2025
Q1 		$12K Sell
1,743
-181
-9% -$1.14K ﹤0.01% 5677
2024
Q4 		$10.2K Sell
1,924
-16,002
-89% -$87.6K ﹤0.01% 5801
2024
Q3 		$65.4K Buy
17,926
+16,272
+984% +$51.2K ﹤0.01% 4548
2024
Q2 		$4.51K Sell
1,654
-2,500
-60% -$8.37K ﹤0.01% 6228
2024
Q1 		$14.5K Buy
4,154
+4,000
+2,597% +$7.4K ﹤0.01% 5536
2023
Q4 		$219 Hold
154
– – ﹤0.01% 7031
2023
Q3 		$224 Hold
154
– – ﹤0.01% 7134
2023
Q2 		$240 Hold
154
– – ﹤0.01% 7173
2023
Q1 		$234 Hold
154
– – ﹤0.01% 7244
2022
Q4 		$0 Hold
154
– – ﹤0.01% 7472
2022
Q3 		$0 Hold
154
– – ﹤0.01% 7559
2022
Q2 		$0 Hold
154
– – ﹤0.01% 7651
2022
Q1 		$0 Hold
154
– – ﹤0.01% 7558
2021
Q4 		$1K Sell
154
-7,581
-98% -$40.9K ﹤0.01% 7272
2021
Q3 		$49K Buy
7,735
+7,581
+4,923% +$62.5K ﹤0.01% 5128
2021
Q2 		$2K Hold
154
– – ﹤0.01% 6767
2021
Q1 		$1K Sell
154
-45,160
-100% -$358K ﹤0.01% 6712
2020
Q4 		$217K Buy
45,314
+917
+2% +$4.47K ﹤0.01% 3411
2020
Q3 		$178K Buy
+44,397
New +$214K ﹤0.01% 3359

Other funds holding NAGE

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
SW
SteelPeak Wealth Woodland Hills, California $3.86B AUM 48.92% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
TCM
Tieton Capital Management Yakima, Washington $348M AUM 45.13% 1-Year Est. Return
Qube Research & Technologies (QRT)
Qube Research & Technologies (QRT) London, United Kingdom $108B AUM 37.29% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
Arrowstreet Capital
Arrowstreet Capital Boston, Massachusetts $225B AUM 49.49% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Osaic Holdings's NAGE Position: Q2 2026 in Review

Osaic Holdings increased its Niagen Bioscience (NAGE) stake by 737% in Q2 2026, buying an estimated $92.6K and bringing the position to 25,922 shares worth $82.7K. The position accounts for ﹤0.01% of the portfolio, ranked #5107.

Osaic Holdings first reported a position in NAGE in Q3 2020 and has held it in 24 quarters since. The position peaked at $217K in Q4 2020. 139 funds tracked by Wall St. Rank hold NAGE as of Q2 2026.

  • Osaic Holdings held 25,922 shares of Niagen Bioscience worth $82.7K as of Q2 2026.
  • Osaic Holdings bought 22,825 Niagen Bioscience shares in Q2 2026, an estimated $92.6K.
  • Niagen Bioscience made up ﹤0.01% of Osaic Holdings's portfolio in Q2 2026, its #5107 holding.
  • Osaic Holdings first reported a position in Niagen Bioscience in Q3 2020 and has held it in 24 quarters since.
  • Osaic Holdings's Niagen Bioscience position peaked at $217K in Q4 2020.
  • 139 funds tracked by Wall St. Rank held Niagen Bioscience as of Q2 2026.

Based on Osaic Holdings's 13F filing for Q2 2026, filed 14 Aug 2026.